FDA.reportPublic FDA data

ruxolitinib 55 MG 24HR Extended Release Oral Tablet

RxCUI
2743041
RxNorm name
ruxolitinib 55 MG 24HR Extended Release Oral Tablet
Display name
ruxolitinib 55 MG 24HR Extended Release Oral Tablet
Full name
ruxolitinib 55 MG 24HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f1c82580-87ae-11e0-bc84-0002a5d5c51bruxolitinib 55 MG 24HR Extended Release Oral TabletPSN40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51b24 HR ruxolitinib 55 MG Extended Release Oral TabletSCD40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51bruxolitinib 55 MG 24 HR Extended Release Oral TabletSY40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501